BioSpace News Archive

ANSYS, Inc., announced that Ajei Gopal, president and chief executive officer, and Nicole Anasenes, chief financial officer and senior vice president of finance, will participate in a moderated discussion at J.P. Morgan’s 51st Annual Global Technology, Media and Communications Conference on Tuesday, May 23, 2023 at 1:55 p.m. ET.

Akumin Inc., a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced its financial results for the quarter ended March 31, 2023.

Genethon is a leader in developing gene therapies for rare and ultra-rare diseases

Innovent Biologics, Inc. announced that the phase 2 clinical study of higher dose mazdutide in Chinese adults with obesity achieved the 24-week primary endpoint.

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, announced that the management team will participate in and attend one-on-one meetings at two upcoming in-person investor conferences.

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today reported financial results and provided a corporate update for the first quarter ended March 31, 2023.

Crinetics Pharmaceuticals, Inc. announced that on May 10, 2023, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 295,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan.

Catalyst Pharmaceuticals, Inc. reported financial results for the first quarter of 2023 and provided a corporate update.

Johnson & Johnson will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m.

Context Therapeutics Inc., a biopharmaceutical company dedicated to improving the lives of patients living with cancer, announced its financial results for the first quarter ended March 31, 2023, and reported on recent and upcoming business highlights.